Business Blog: The year for women’s health

This is the year to invest in women's health. Here's why

May 31, 2024

Anu Duggal, the founding partner at Female Founders Fund, guest wrote today's Term Sheet essay on how women's health has been ignored for most of history, and why this is the year to double down.

After her doctor misdiagnosed her perimenopause as herpes, Halle Berry knew it was time to open a national conversation. Earlier this Women's Health Month, the actress joined a group of U.S. senators outside the Capitol Building to call for more federal funding for research into a critical part of the female experience that should not be hard to fund, let alone discuss. "The shame has to be taken out of menopause," she said. "We have to talk about this very normal part of our life that happens."

Just having this public conversation is groundbreaking. Ten years ago, the word "menopause" was barely uttered. "Women's health" as a category did not exist for patients, entrepreneurs, employers, or investors. You'd have been shocked to find fertility care, maternity benefits, or IVF offered by America's largest employers. Back then, my industry—venture capital—did not even consider women's health an investable category.

Against that backdrop, almost exactly 10 years ago, I met Kate Ryder. Then a former journalist, Kate wanted to tackle the infamously-bureaucratic, slow-moving healthcare industry–a system that is hesitant to adopt new technology and, until recently, treated women's health just like men's health, ignoring the complex hormonal changes throughout a woman's life. In fact, the inclusion of women in clinical trials did not become law until the early 1990s.

Kate's vision—for a healthcare experience that would put the female patient at the center of care for the first time—was incredibly compelling and visionary. My firm, Female Founders Fund, went on to write one of our first checks to Maven Clinic, getting a front-row seat as Kate built the first women's health unicorn. Maven Clinic is now worth $1.35 billion and serves more than 2,000 employers, including giant corporations like Microsoft and AT&T. But more important than the statistics is that Kate convinced employers that it is imperative to provide better benefits for women, and she helped prove to venture investors—and the medical industry—that women's health has massive potential as a business that is well worth the investment.

Since then, I've seen the tide shift as more and more founders and investors put money into women's health. A great example: A few years ago, I was pitched by two women building a more holistic care model for pregnancy, combining the best aspects of obstetric care and midwifery care into an evidence-based birth program tailored to each mother's unique wants and needs. And with the U.S. having the worst maternal mortality rate of all developed nations, the pregnancy and birthing experience needed to change. Adrianne and Elaine of Oula were convinced that there was a better solution, again putting the female patient experience at the center.

Oula has now raised more than $50 million in funding from investors, including Female Founders Fund, and has facilitated over 1,500 births with a 26% better C-section rate compared to New York City benchmarks and a 61% lower preterm birth rate—all while maintaining an NPS customer experience score greater than 90.

Just as encouraging are the successful startups that are not inside our portfolio.

Midi Health provides virtual care for women in menopause and perimenopause, and the results of this well-tailored care have been incredible. Around 91% of their patients report improving symptoms after just two months of care. Over 94% of patients see improvement in hot flashes in three months, 93% of patients report less insomnia in the first five months and 92% claim their moods improved in just two months. The company has raised over $100M to date, provides care in all 50 states, and now partners with major healthcare systems like Memorial Hermann and benefit-providers like Progyny and Cleo.

And there are many other examples over the last decade, such as Kindbody, Carrot, Clue, Alife Health, that show things are changing. Women are benefiting from improved solutions across a multitude of life experiences: menopause, IVF, endometriosis, fertility, hormone health, childbirth, osteoporosis, cancer diagnosis, and much more. The social momentum is building, too. Advocates like Elaine Welteroth and Serena Williams are raising awareness of critical issues of better maternal options with the launch of the Birth Fund earlier this year. Last year, President and Dr. Biden announced $100 million for women's health initiatives and called on Congress to invest $12 billion in research—a move that was widely and rightly applauded. Of course, despite the progress, we still have a long way to go. Disproportionate funding is allocated toward diseases primarily affecting men, while the majority of medical professionals are still brushing off women's pain instead of treating it.

But if there's ever been a year to capitalize on the momentum of women, it's this year; It's right now, as the medical community finally begins to acknowledge women have evolving health needs across each stage of their lives.

You can read the full essay here.

Anu Duggal
Submit a deal for the Term Sheet newsletter here.

Joe Abrams curated the deals section of today’s newsletter.

VENTURE DEALS

- Babylon, a Palo Alto, Calif.-based Bitcoin staking protocol, raised $70 million in funding. Paradigm led the round and was joined by Bullish Capital, Polychain Capital, and others.

- Rhea, a Singapore and New York City-based network of reproductive health clinics, raised $10 million in funding. Thiel Capital led the round and was joined by LifeX Ventures, Blue Lion Global, and FJ Labs.

- Weave Bio, a New Haven, Conn.-based platform designed to automate the preparation, writing, and review process for investigational new drug applications, raised $10 million in seed funding from Innovation Endeavors and Magnetic Ventures.

- Basalt, a San Francisco-based developer of an operating system for satellite operators, raised $3.5 million in seed funding. Initialized Capital led the round and was joined by Y Combinator, Liquid2, General Catalyst, and others.

- (Re)vive, a New York City-based company that helps retailers sell their returned or dead stock items, raised $3.5 million in seed funding. Equal Ventures and Hustle Fund led the round and was joined by Banter Capital, Coalition Operators, Mute VC, Veronica Chou, and others.

- Plural Energy, a San Francisco-based investing platform that tokenizes clean energy assets like solar projects, raised $2.3 million in pre-seed funding. Necessary Ventures and Compound led the round and was joined by Volt Capital and Maven11.

- Kalogon, a Melbourne, Fla.-based developer of smart wheelchair cushions designed for pain relief, blood flow, and posture improvement, raised $1.2 million in a seed extension from Sawmill Angels, M7, SeedFundersOrlando, AARP, and angel investors.

PRIVATE EQUITY

- ACA Group, backed by Genstar, agreed to acquire UMB Fund Services, a Kansas City, Mo.-based provider of investment fund administration services, from UMB Financial Corporation (NASDAQ: UMBF). Financial terms were not disclosed.

- Agilence, backed by Cuadrilla Capital, acquired IntelliQ, a London, U.K.-based fraud prevention platform for retailers, restaurants, and entertainment companies. Financial terms were not disclosed.

- Angeles Equity Partners acquired O'Hara's Son Roofing, a Chicago, Ill.-based commercial and industrial roofing provider. Financial terms were not disclosed.

- KKR agreed to acquire a majority stake in Agiloft, a Redwood City, Calif.-based contract lifecycle management platform. Financial terms were not disclosed.

- Marlin Equity Partners acquired Traace, a Paris, France-based carbon use management and ESG monitoring platform. Financial terms were not disclosed.

- Tencarva Machinery Company, backed by Bessemer Investors, acquired Tri-State Coating & Machine, a Salt Rock, W.V.-based provider of thermal coating services and related parts to industrial companies. Financial terms were not disclosed.

- Vista Equity Partners led a minority investment in Portside, a Cary, N.C.-based developer of software for business and government aviation. Insight Partners also participated. Financial terms were not disclosed.

The AI revolution is here

Are you ready?

Each week, Eye on AI explores how artificial intelligence and machine learning models are revolutionizing business and society.

EXITS

- Asplundh Tree Expert, backed by The Carlyle Group, acquired Voltyx, a Nashville, Tenn.-based provider of electrical grid maintenance, repair, engineering, and other services, from Arcline Investment Management and Industrial Growth Partners. Financial terms were not disclosed.

- Uhuru Investment Partners acquired Cresta Paints, an Accra, Ghana-based paint and industrial coatings manufacturer, from Adenia Partners. Financial terms were not disclosed.

OTHER

- Cloudflare (NYSE: NET) acquired BastionZero, a Boston, Mass.-based platform designed for IT and security teams to manage remote access to a company's systems. Financial terms were not disclosed.

PEOPLE

- Renovus Capital Partners, a Philadelphia, Pa.-based private equity firm, hired Gary Tang as principal. Formerly, he was with Chicago Pacific Founders.